CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Open-market sale Chief Commercial Officer sold 10,439 shares at an average $5.85 ($61,034)
- 4 Grant or award See Remarks acquired 46,200 shares (grant or award)
- 4 Grant or award See Remarks acquired 103,080 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 85,670 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 137,945 shares (grant or award)
- 4 Grant or award President & CEO acquired 446,220 shares (grant or award)
- 4 Grant or award Chief Human Resources Officer acquired 99,455 shares (grant or award)
- 4 Grant or award Chief Patient Officer acquired 82,695 shares (grant or award)
- 4 Grant or award See Remarks acquired 124,330 shares (grant or award)
- 4 Planned sale Chief Patient Officer sold 50,000 shares at $6.98 ($348,900)
- 4 Open-market sale See Remarks sold 5,995 shares at $5.54 ($33,194)
- 4 Open-market sale President & CEO sold 46,887 shares at $5.54 ($259,609)
- 4 Open-market sale See Remarks sold 5,560 shares at $5.54 ($30,785)
- 4 Open-market sale Chief Patient Officer sold 6,426 shares at $5.54 ($35,580)
- 4 Open-market sale Chief Commercial Officer sold 5,814 shares at $5.54 ($32,192)
- 4 Open-market sale See Remarks sold 11,086 shares at $5.54 ($61,382)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 35 · 690 filings